Emory University-Winship Cancer Institute: FDA Approves Winship-Tested Immunotherapy Combination
May 19, 2020
May 19, 2020
ATLANTA, Georgia, May 19 -- Emory University's Winship Cancer Institute issued the following news release:
The U.S. Food and Drug Administration (FDA) announced approval of a novel combination of immunotherapy drugs as a first-line treatment option for patients with metastatic non-small cell lung cancer, based on a trial held at Winship and other sites. Suresh Ramalingam, MD, deputy director of Winship Cancer Institute of Emory University, will present the updated results from . . .
The U.S. Food and Drug Administration (FDA) announced approval of a novel combination of immunotherapy drugs as a first-line treatment option for patients with metastatic non-small cell lung cancer, based on a trial held at Winship and other sites. Suresh Ramalingam, MD, deputy director of Winship Cancer Institute of Emory University, will present the updated results from . . .